Clinical Trial Update: Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tirzepatide's effects on alcohol intake in adults with schizophrenia and alcohol use disorder; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Schizophrenia

Drugs mentioned

• MOUNJARO (tirzepatide)

Snippet

Sponsor: Anders Fink-Jensen, MD, DMSci | Conditions: Alcohol Use Disorder, Alcohol Abuse/Dependence | Phase 2 | Status: RECRUITING